ZA963269B - Modified polypeptides for enhanced immunogenicity - Google Patents

Modified polypeptides for enhanced immunogenicity

Info

Publication number
ZA963269B
ZA963269B ZA963269A ZA963269A ZA963269B ZA 963269 B ZA963269 B ZA 963269B ZA 963269 A ZA963269 A ZA 963269A ZA 963269 A ZA963269 A ZA 963269A ZA 963269 B ZA963269 B ZA 963269B
Authority
ZA
South Africa
Prior art keywords
modified polypeptides
enhanced immunogenicity
immunogenicity
enhanced
polypeptides
Prior art date
Application number
ZA963269A
Other languages
English (en)
Inventor
Nicolas Joseph Fasel
Christopher Dominique Reymond
Original Assignee
Rmf Dictagene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rmf Dictagene Sa filed Critical Rmf Dictagene Sa
Publication of ZA963269B publication Critical patent/ZA963269B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA963269A 1995-04-25 1996-04-24 Modified polypeptides for enhanced immunogenicity ZA963269B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/428,616 US6113917A (en) 1995-04-25 1995-04-25 Modified polypeptides for enhanced immunogenicity
EP95201066 1995-04-25

Publications (1)

Publication Number Publication Date
ZA963269B true ZA963269B (en) 1996-10-25

Family

ID=26139248

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA963269A ZA963269B (en) 1995-04-25 1996-04-24 Modified polypeptides for enhanced immunogenicity

Country Status (15)

Country Link
US (1) US6113917A (xx)
EP (1) EP0826050A1 (xx)
JP (1) JPH11504215A (xx)
AU (1) AU714808B2 (xx)
BR (1) BR9604989A (xx)
CA (1) CA2218987A1 (xx)
CZ (1) CZ291013B6 (xx)
HU (1) HUP9802238A3 (xx)
IL (1) IL118021A0 (xx)
NL (1) NL1001348C2 (xx)
NO (1) NO974924L (xx)
NZ (1) NZ307195A (xx)
PL (1) PL323078A1 (xx)
WO (1) WO1996034105A1 (xx)
ZA (1) ZA963269B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997026911A1 (en) * 1996-01-29 1997-07-31 Georgetown University Malaria vaccine based upon the addition of a msa1 peptide
AUPP589398A0 (en) * 1998-09-14 1998-10-08 Walter And Eliza Hall Institute Of Medical Research, The Immunogenic compositions and uses thereof
AUPP675898A0 (en) * 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of activating t cells and agents useful for same
KR20050035511A (ko) * 2001-10-13 2005-04-18 아스테리온 리미티드 폴리펩타이드들을 포함하는 글리코실포스파티딜이노시톨
US20030171260A1 (en) * 2002-03-11 2003-09-11 Nelson Deanna Jean Compositions and methods utilizing hydroxamates to scavenge oxidant toxins
BR0312985A (pt) 2002-07-26 2005-06-21 Inst Medical W & E Hall Métodos para extrair ou induzir, em um mamìfero, uma resposta imune dirigida a um parasita, para tratar de modo terapêutico ou profilático um mamìfero para infecção por parasitas, para o tratamento e/ou a profilaxia de uma condição doentia de mamìfero, uso de uma composição,composição, composição de vacina, composição farmacêutica, anticorpo para inibir, parar ou retardar o inìcio ou progressão de uma condição doentia de mamìfero, uso de um anticorpo, métodos para detectar, em uma amostra bológica, uma molécula imunointerativa dirigida a um microorganismo e para detectar, monitorar ou de outra forma avaliar uma resposta imune dirigida a um microorganismo em um indivìduo, kit modular, método para analisar, projetar e/ou modificar um agente capaz de interagir com um sìtio de ligação de molécula imunointerativa anti-gpi glicano, e, uso do agente
WO2004090135A2 (en) * 2003-04-09 2004-10-21 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol
US20080026008A1 (en) * 2006-07-27 2008-01-31 Clark Tibbs Bacteriophage DNA vaccine vector

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8905857D0 (en) * 1989-03-14 1989-04-26 Hoffmann La Roche Plasmodium merozoite rhoptries antigen
NL9100869A (nl) * 1991-05-17 1992-12-16 Univ Lausanne Dictyostelide expressievector en werkwijze voor het tot expressie brengen van een gewenst eiwit.
BR9400600A (pt) * 1994-02-17 1995-10-24 Finep Financiadora De Estudos Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos

Also Published As

Publication number Publication date
NL1001348C2 (en) 1996-10-28
HUP9802238A2 (hu) 1999-01-28
JPH11504215A (ja) 1999-04-20
NO974924D0 (no) 1997-10-24
CZ291013B6 (cs) 2002-11-13
BR9604989A (pt) 1999-11-30
AU714808B2 (en) 2000-01-13
NZ307195A (en) 1999-07-29
NO974924L (no) 1997-12-19
AU5648196A (en) 1996-11-18
IL118021A0 (en) 1996-08-04
PL323078A1 (en) 1998-03-02
CZ337897A3 (cs) 1998-04-15
WO1996034105A1 (en) 1996-10-31
CA2218987A1 (en) 1996-10-31
HUP9802238A3 (en) 2000-03-28
EP0826050A1 (en) 1998-03-04
US6113917A (en) 2000-09-05

Similar Documents

Publication Publication Date Title
EP0793502A4 (en) NEW POLYPEPTIDES DERIVED FROM HEDGEHOG
ZA965459B (en) Vaccines
PT1090128E (pt) Polipéptidos dependentes da vitamina k modificados
HUP9800299A3 (en) Gnrh-leukotoxin chimeras
GB9500601D0 (en) Modified peptides
PL318017A1 (en) Peptides
EP0746565A4 (en) PEPTIDES RELATED TO BOMBESIN
IL118021A0 (en) Modified polypeptides for enhanced immunogenicity
GB9425380D0 (en) Peptides
GB9519511D0 (en) Peptides
GB2308509B (en) Services-connections for trailer-vehicles
GB9425381D0 (en) Peptides
GB2308393B (en) Windshelter for sun-bathing
GB2298174B (en) Services-connections for trailer-vehicles
EP0873349A4 (en) TYPE III POLYPEPTIDE ACTIVATOR OF MONOCYTES AND ENDOTHELIAL CELLS
GB9514835D0 (en) Polypeptide
GB9514580D0 (en) Polypeptide
GB9511092D0 (en) Peptides
ZA956331B (en) Peptides
GB9421408D0 (en) Peptides
GB9513260D0 (en) Vaccines
ZA962036B (en) Vaccines
GB9512827D0 (en) Vaccines
ZA962612B (en) Vaccines
GB9513107D0 (en) Vaccines